Purdue Pharma, OxyContin and Sacklers
Purdue Pharma’s bankruptcy plan was approved by a federal judge Sept. 1, meaning the company that made and marketed the opioid Oxycontin will be dissolved, The New York Times reported. Judge ...
The $7.4 billion settlement plan proposed by OxyContin maker Purdue Pharma and the Sackler family members who own the bankrupt firm has gained nearly unanimous creditor approval. More than ...
NEW YORK, Oct 21 (Reuters) - More than 99% of bankrupt drugmaker Purdue Pharma's creditors voted to accept a $7.4 billion settlement of legal claims related to the company's sales of addictive ...
A majority of Purdue Pharma’s more than 120,000 creditors have voted to approve the company’s bankruptcy plan, The New York Times reported July 27. Ninety-five percent of cities, states, ...
Purdue Pharma, which is owned by the Sackler family, manufactures and markets OxyContin -- one of the prescription ...
STAMFORD, Conn.--(BUSINESS WIRE)--Purdue Pharma L.P. (“Purdue”) today announced that its Chapter 11 Plan of Reorganization (“Plan”) received support from more than 99% of voting creditors, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results